Jyong Biotech Ltd. (Nasdaq: MENS) (the “Company” or “Jyong Biotech”), a science-driven biotechnology company dedicated to the development and commercialization of innovative plant-derived therapeutics ...
CEO of BigHat Biosciences, which designs antibody therapies using machine-learning, on how AI can, and cannot, help in drug ...
How the ouster of key officials at the FDA has created anxiety and uncertainty for the developers of rare disease drugs.
Recorded last week at Fierce Biotech Week in Boston, this episode of “The Top Line” features a conversation with Kristen ...
REHOVOT, Israel, March 13, 2026 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. (NASDAQ/TASE: PPBT), a clinical-stage company developing next-generation cancer therapies, today announced that Gil Efron, Chief ...
Marie Saavedra joined the CBS2 Chicago news team in October 2020 as an anchor. She grew up in Evanston and is a graduate of the Missouri School of Journalism. A CEO at a Chicago biotech company is ...
Develops monoclonal antibodies (e.g. Sotrovimab/Xevudy for COVID-19), RNAi therapeutics for hepatitis B, and investigational therapies for influenza A and HIV. Generates revenue through product sales, ...
From Eli Lilly's David Ricks to Pfizer's Albert Bourla, the top five highest paid CEOs made a combined $157.8 million in 2025 ...
Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnology company developing the investigational oral therapy, buntanetap, for neurodegenerative diseases such ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results